A detailed history of Simplex Trading, LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 16,083 shares of ITOS stock, worth $163,403. This represents 0.01% of its overall portfolio holdings.

Number of Shares
16,083
Holding current value
$163,403
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$10.33 - $18.09 $166,137 - $290,941
16,083 New
16,083 $238,000
Q4 2023

Feb 02, 2024

BUY
$8.57 - $11.06 $55,070 - $71,071
6,426 New
6,426 $70,000
Q2 2023

Aug 04, 2023

BUY
$12.93 - $18.05 $122,356 - $170,807
9,463 Added 463.87%
11,503 $152,000
Q1 2023

Apr 27, 2023

SELL
$13.02 - $22.62 $4,986 - $8,663
-383 Reduced 15.81%
2,040 $27,000
Q4 2022

Feb 02, 2023

BUY
$17.77 - $21.6 $41,777 - $50,781
2,351 Added 3265.28%
2,423 $47,000
Q3 2022

Nov 04, 2022

SELL
$18.6 - $27.25 $207,073 - $303,374
-11,133 Reduced 99.36%
72 $1,000
Q2 2022

Aug 03, 2022

BUY
$16.57 - $35.1 $185,666 - $393,295
11,205 New
11,205 $230,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $361M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.